Skip to main content

Beneficial ownership — 13D / 13G

87,314 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Nuveen Asset Management, LLC AMBR Amber International Holding Ltd 13G/A 5.33% 2y
Radcliffe Capital Management, L.P. HPLT Home Plate Acquisition Corporation Class A Common Stock 13G/A 0% 2y
Michael J. Saylor MSTR Strategy Inc 13G/A 13.9% 2y
CI INVESTMENTS INC. HESM Hess Midstream LP 13G/A 2.87% 2y
PRICE T ROWE ASSOCIATES INC /MD/ SPR Spirit Aerosystems Holdings, Inc. 13G/A 8.6% 2y
Black Horse Capital LP BXRX Baudax Bio, Inc. Common Stock 13G/A 0% 2y
ARMISTICE CAPITAL, LLC PTCT Ptc Therapeutics, Inc. 13G 9.1% 2y
NOMURA HOLDINGS INC TRLV Trulieve Cannabis Corp. 13G 7.3% 2y
PRICE T ROWE ASSOCIATES INC /MD/ CEG Constellation Energy Corp 13G 6.1% 2y
Jin Qiong GDHG Golden Heaven Group Holdings Ltd. 13G 29% 2y
Select Equity Group, L.P. CNM Core & Main, Inc. 13G/A 5.1% 2y
Riel B.V. TIXT TELUS International (Cda) Inc. Subordinate Voting Shares 13G/A 39.2% 2y
Berkshire Hathaway Inc GL Globe Life Inc. 13G/A 0% 2y
SVB FINANCIAL GROUP ROOT Root, Inc. 13G/A 8.2% 2y
HG Vora Capital Management, LLC BALY Bally's Corp 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. RRGB Red Robin Gourmet Burgers Inc 13G/A 0% 2y
Deep Track Capital, LP ALBO Albireo Pharma, Inc. Common Stock 13G/A 0% 2y
Atlas Merchant Capital LLC LOCC Live Oak Crestview Climate Acquisition Corp. 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ DAVA Endava plc 13G/A 17.8% 2y
Blue Owl Capital Holdings LP ENGN enGene Therapeutics Inc. 13G 5.32% 2y
Harvey Partners, LLC THR Thermon Group Holdings, Inc. 13G/A 4.4% 2y
MACKENZIE FINANCIAL CORP CRI Carters Inc 13G/A 0% 2y
Randall J. Levitt CBNK Capital Bancorp Inc 13G/A 7.32% 2y
PRICE T ROWE ASSOCIATES INC /MD/ COR Cencora, Inc. 13G 5.4% 2y
Radcliffe Capital Management, L.P. MBAC M3-Brigade Acquisition II Corp. 13G/A 0% 2y
T. Rowe Price Investment Management, Inc. XPRO Expro Ltd 13G 6.7% 2y
D. E. Shaw & Co., L.P. ROSE Rose Hill Acquisition Corporation Class A Ordinary Shares 13G/A 0% 2y
ARMISTICE CAPITAL, LLC IPCI Intellipharmaceuticals International Inc. 13G/A 0% 2y
CVC Credit Partners, LLC VNTR Venator Materials PLC 13G 6.6% 2y
Calamos Market Neutral Income Fund, a series of Calamos Investment Trust AEAE AltEnergy Acquisition Corp 13G 0% 2y
GCM Investments GP, LLC CART Maplebear Inc. 13G 3.2% 2y
Radcliffe Capital Management, L.P. AXAC AXIOS Sustainable Growth Acquisition Corporation 13G/A 0% 2y
METEORA CAPITAL, LLC CNGL Canna-Global Acquisition Corp. Class A Common Stock 13G 9.27% 2y
Point72 Asset Management, L.P. ESPR Esperion Therapeutics, Inc. 13G/A 0.2% 2y
Point72 Asset Management, L.P. ANAB Anaptysbio, Inc 13G/A 3% 2y
PERCEPTIVE ADVISORS LLC CBAY Cymabay Therapeutics 13G/A 3.5% 2y
T. Rowe Price Investment Management, Inc. PMT PennyMac Mortgage Investment Trust 13G 7% 2y
TURTLE CREEK ASSET MANAGEMENT INC. ECPG Encore Capital Group Inc 13G/A 8.6% 2y
EMINENCE CAPITAL, LP ETWO E2open Parent Holdings, Inc. 13G/A 0% 2y
PRICE T ROWE ASSOCIATES INC /MD/ MPWR Monolithic Power Systems, Inc. 13G 4.6% 2y
PRICE T ROWE ASSOCIATES INC /MD/ TDY Teledyne Technologies Inc 13G/A 10.4% 2y
Solel Partners LP LAW CS Disco, Inc. 13G 5.5% 2y
Commodore Capital LP VRDN Viridian Therapeutics, Inc.DE 13G/A 3.7% 2y
First Trust Capital Management L.P. NNAG 99 Acquisition Group Inc. Class A Common Stock 13G 5.28% 2y
Eric Remer EVCM EverCommerce Inc. 13G/A 8.1% 2y
Mudrick Capital Management, L.P. EVTL Vertical Aerospace Ltd. 13G/A 10.4% 2y
GLAZER CAPITAL, LLC NCAC Newcourt Acquisition Corp Class A Ordinary Share 13G/A 0.21% 2y
M3 Funds, LLC PROV Provident Financial Holdings Inc 13G/A 9.3% 2y
METEORA CAPITAL, LLC OPA Magnum Opus Acquisition Limited 13G 9.15% 2y
PRICE T ROWE ASSOCIATES INC /MD/ TRDA Entrada Therapeutics, Inc. 13G/A 9% 2y